Submission Details
| 510(k) Number | K233986 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 18, 2023 |
| Decision Date | March 15, 2024 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K233986 is an FDA 510(k) clearance for the BD Phoenix? Automated Microbiology System - GN Ciprofloxacin (0.0156?4 ?g/mL), a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II — Special Controls, product code LON), submitted by Becton, Dickinson and Company (Sparks, US). The FDA issued a Cleared decision on March 15, 2024, 88 days after receiving the submission on December 18, 2023. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1645.
| 510(k) Number | K233986 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 18, 2023 |
| Decision Date | March 15, 2024 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LON — System, Test, Automated, Antimicrobial Susceptibility, Short Incubation |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1645 |